Vertex Pharmaceuticals Incorporated which can be found using ticker (VRTX) have now 26 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between 456 and 305 calculating the average target price we see $367.80. Given that the stocks previous close was at $350.40 this would imply there is now a potential upside of 5.0%. It’s also worth noting that there is a 50 day moving average of $319.67 and the 200 moving average now moves to $303.57. The market capitalization for the company is 90.15B. The stock price is currently at: 347.41 USD
The potential market cap would be $94,630,026,058 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 27.93, revenue per share of 35.87 and a 16.8% return on assets.
